Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Masaya Tachi"'
1
Akademický článek
Identification of regions maintaining atrial fibrillation through cycle length and cycle length gradient mapping
Autor: Masafumi Shimojo, Yasuya Inden, Satoshi Yanagisawa, Ryota Yamauchi, Kei Hiramatsu, Tomoya Iwawaki, Masaya Tachi, Shun Kondo, Takayuki Goto, Yukiomi Tsuji, Toyoaki Murohara
Publikováno v: Journal of Arrhythmia, Vol 40, Iss 6, Pp 1389-1399 (2024)
Abstract Background Visualizing the specific regions where atrial fibrillation (AF) is maintained is crucial for effective treatment, but it remains challenging in clinical practice. We aimed to address this challenge by developing a mapping approach
Externí odkaz: https://doaj.org/article/5ef66b2dce0643ef9b80a2377cc32f4c
Zobrazit plný text záznamu
2
Akademický článek
A Novel Liver Fibrosis Marker FIB‐5 Index Predicted Response to Cardiac Resynchronization Therapy and Prognostic Outcomes in Patients With Heart Failure
Autor: Tomoya Iwawaki, Yasuya Inden, Satoshi Yanagisawa, Takayuki Goto, Shun Kondo, Masaya Tachi, Kei Hiramatsu, Ryota Yamauchi, Masafumi Shimojo, Yukiomi Tsuji, Toyoaki Murohara
Publikováno v: Annals of Noninvasive Electrocardiology, Vol 29, Iss 5, Pp n/a-n/a (2024)
ABSTRACT Background The fibrosis‐5 (FIB‐5) index is a noninvasive marker for assessing the progression of liver fibrosis and predictor in patients with heart failure (HF). This study investigated the association between the FIB‐5 index and resp
Externí odkaz: https://doaj.org/article/875fd5139dd740f883f72e6927bc07c9
Zobrazit plný text záznamu
3
Akademický článek
Bayesian sparse regression for exposure–response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T‐cell leukemia/lymphoma
Autor: Masato Fukae, James Rogers, Ramon Garcia, Masaya Tachibana, Takako Shimizu
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 10, Pp 1655-1669 (2024)
Abstract Valemetostat is an oral inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1 approved in Japan for the treatment of adult T‐cell leukemia/lymphoma (ATLL). To support the approved daily dose of 200 mg and inform dose adjustments in patie
Externí odkaz: https://doaj.org/article/c41d9e15557546d19891d4fdc2b0a0ed
Zobrazit plný text záznamu
4
Akademický článek
Population pharmacokinetics of total and unbound valemetostat and platelet dynamics in healthy volunteers and patients with non‐Hodgkin lymphoma
Autor: Masato Fukae, Kyle Baron, Masaya Tachibana, John Mondick, Takako Shimizu
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 10, Pp 1641-1654 (2024)
Abstract Valemetostat is an EZH2/1 inhibitor that has been approved in Japan for the treatment of patients with relapsed/refractory adult T‐cell leukemia/lymphoma, based mainly on results from a single‐arm phase II trial. It is currently under in
Externí odkaz: https://doaj.org/article/fc97c850f0cc4f17b8c5def4c6355633
Zobrazit plný text záznamu
6
Akademický článek
Altered white matter connectivity of ventral language networks in autism spectrum disorder: An automated fiber quantification analysis with multi-site datasets
Autor: Min Li, Maya Izumoto, Yide Wang, Yoko Kato, Yoshiko Iwatani, Ikuko Hirata, Yoshifumi Mizuno, Masaya Tachibana, Ikuko Mohri, Kuriko Kagitani-Shimono
Publikováno v: NeuroImage, Vol 297, Iss , Pp 120731- (2024)
Comprehension and pragmatic deficits are prevalent in autism spectrum disorder (ASD) and are potentially linked to altered connectivity in the ventral language networks. However, previous magnetic resonance imaging studies have not sufficiently explo
Externí odkaz: https://doaj.org/article/b46f6e79a68742138bb3694fbabaf953
Zobrazit plný text záznamu
7
Akademický článek
Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open‐label, phase I study in healthy subjects
Autor: Masaya Tachibana, Shunji Matsuki, Yutaro Maekawa, Kana Kuroda, Takako Shimizu, Junko Tsutsumi, Hitoshi Ishizuka
Publikováno v: Clinical and Translational Science, Vol 16, Iss 11, Pp 2153-2162 (2023)
Abstract Valemetostat tosylate (valemetostat) is an oral, potent, dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1 under investigation for the treatment of cancer, including non‐Hodgkin's lymphomas and solid tumors. Itraconazole and flu
Externí odkaz: https://doaj.org/article/25cca946004140688edddbbed881b3b2
Zobrazit plný text záznamu
9
Akademický článek
Prostaglandin E2 receptor Ptger4b regulates female-specific peptidergic neurons and female sexual receptivity in medaka
Autor: Thomas Fleming, Yukiko Kikuchi, Mikoto Nakajo, Masaya Tachizawa, Tomoaki Inazumi, Soken Tsuchiya, Yukihiko Sugimoto, Daisuke Saito, Mikita Suyama, Yasuyuki Ohkawa, Takashi Baba, Ken-ichirou Morohashi, Kataaki Okubo
Publikováno v: Communications Biology, Vol 5, Iss 1, Pp 1-13 (2022)
Prostaglandin E2 signaling mediates the estrogenic regulation of peptidergic neuronal activity and female receptivity via the ptger4b gene pathway in Japanese rice fish.
Externí odkaz: https://doaj.org/article/d24dded19afc48448cb8ae3743921e1c
Zobrazit plný text záznamu
10
Akademický článek
Relationship between children with neurodevelopmental disorders and their caregivers and friends during early phase of COVID-19 school closure in Japan: Association with difficulty in implementing infection prevention measures
Autor: Tomoka Yamamoto, Sanae Tanaka, Arika Yoshizaki, Yuko Yoshimura, Aishah Ahmad Fauzi, Aida Syarinaz, Ahmad Adlan, Subhashini Jayanath, Norhamizan Hamzah, Haruo Fujino, Masaya Tachibana
Publikováno v: Child and Adolescent Psychiatry and Mental Health, Vol 16, Iss 1, Pp 1-9 (2022)
Abstract Background Due to the COVID-19 pandemic people had to implement various infection prevention measures. Researchers have reported the difficulties experienced by children with neurodevelopmental disorders in implementing these measures and th
Externí odkaz: https://doaj.org/article/ddbc0236385d4d88ac6146aa3ae666ce
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje